Holen Sie sich die Stockscreener-App
2.25
2.74%
0.06
Schlusskurs vom Vortag:
$2.19
Offen:
$2.27
24-Stunden-Volumen:
7,098
Relative Volume:
0.18
Marktkapitalisierung:
$2.21M
Einnahmen:
$7.68M
Nettoeinkommen (Verlust:
$-34.33M
KGV:
-0.0255
EPS:
-88.1566
Netto-Cashflow:
$-19.17M
1W Leistung:
+7.14%
1M Leistung:
-28.12%
6M Leistung:
-78.17%
1J Leistung:
-95.37%
1-Tages-Spanne:
$2.16
$2.27
1-Wochen-Bereich:
$2.07
$2.29
52-Wochen-Spanne:
$2.05
$53.20
Beyond Air Inc Stock (XAIR) Company Profile
Firmenname
Beyond Air Inc
Sektor
Branche
Telefon
516-665-8200
Adresse
900 STEWART AVENUE, GARDEN CITY, NY
Compare XAIR vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XAIR
Beyond Air Inc
|
2.25 | 2.21M | 7.68M | -34.33M | -19.17M | -88.16 |
ABT
Abbott Laboratories
|
98.69 | 170.77B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
93.41 | 119.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
294.99 | 113.15B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
44.16 | 64.01B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.72 | 50.56B | 6.30B | 1.07B | 1.09B | 1.8406 |
Beyond Air Inc Stock (XAIR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-01 | Eingeleitet | Lake Street | Buy |
| 2025-07-17 | Eingeleitet | D. Boral Capital | Buy |
| 2024-06-25 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-07-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-06-15 | Eingeleitet | BTIG Research | Buy |
| 2021-04-28 | Eingeleitet | Truist | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Outperform |
Alle ansehen
Beyond Air Inc Aktie (XAIR) Neueste Nachrichten
Beyond Air Stock Price Forecast. Should You Buy XAIR? - StockInvest.us
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $5,761 in company stock By Investing.com - Investing.com South Africa
Beyond Air director Lin Yi-Chien buys $5,761 in company stock - Investing.com
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com Canada
Form 4 Beyond Air Inc: Yi-Chien Lin (10% Owner) For: 13 October - Investing.com UK
At $2.21 a share, Beyond Air (XAIR) ten percent owner Lin Yi-Chien buys 2,607 shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $5,761 in company stock - Investing.com Nigeria
Top insider buys and sells disclosed on Friday - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com UK
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Nigeria
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com
Form 4 Beyond Air Inc For: 2 October By Investing.com - Investing.com Australia
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com UK
A 10% owner buys 20,393 shares of Beyond Air (XAIR) in three direct purchases. - Stock Titan
Ten percent owner Lin Yi-Chien holds 125,000 shares directly in Beyond Air (XAIR). - Stock Titan
Form 3 Beyond Air, Inc. For: Sep 28 Filed by: Lin Yi-Chien - StreetInsider
One holder reports sole voting power over 145,393 Beyond Air (XAIR) shares. - Stock Titan
Beyond Air director Lin Yi-Chien buys $56,590 in company stock - Investing.com Canada
Why Beyond Meat (BYND) Shares Are Getting Obliterated Today - Yahoo Finance
XAIR: Generation 2 device approval is set to unlock a $400M+ market with immediate deployment planned - TradingView
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com Canada
XAIR: Generation 2 enables immediate entry into the $400M U.S. transport market upon FDA approval - TradingView
Beyond Air at cantors conference: generation 2 is the focus - Investing.com India
Beyond Air at cantors conference: generation 2 is the focus By Investing.com - Investing.com UK
At the Waldorf Astoria, Beyond Air joins a healthcare conference Sept. 10 - Stock Titan
XAIR Initiates Coverage On Beyond Air -- Rating Set to Buy - GuruFocus
ENvue Medical Announces Reverse Stock Split to Reduce Shares to 923,718 (NASDAQ: FEED) - Kalkine Media
Lake Street Initiates Beyond Air at Buy With $10 Price Target - marketscreener.com
XAIR Looks 98.9% Undervalued on GF Value™ Despite Financial Stru - GuruFocus
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - The Manila Times
Beyond Air Announces FDA Breakthrough Device Designation for LungFit GO in NTM-PD Treatment - Quiver Quantitative
A portable treatment for hard-to-treat lung infections gets FDA breakthrough status - Stock Titan
Beyond Air® Receives FDA Breakthrough Device Designation for LungFit® GO to Treat Nontuberculous Mycobacterial Pulmonary Disease (NTM-PD) - Yahoo Finance
Beyond Air to Sell NeuroNOS Stake to UNIVO in Equity, Milestone Deal - citybiz
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com Nigeria
Beyond Air to sell NeuroNOS stake to Univo for 19.99% equity By Investing.com - Investing.com India
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - marketscreener.com
Beyond Air Enters Definitive Agreement to Sell Its NeuroNOS Stake to UNIVO Pharmaceutical Industries in Exchange for Equity and Milestone Payments - Yahoo Finance
Balyasny Asset Management L.P. Buys Beyond Air Inc (XAIR) -- Sha - GuruFocus
Beyond Air | 8-K: Beyond Air® Reports Financial Results for the Quarter Ended June 30, 2026 and Provides Corporate Update - Moomoo
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Nigeria
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com India
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com Canada
Form 8K Beyond Air Inc For: 18 August By Investing.com - Investing.com UK
Beyond Air (NASDAQ: XAIR) resale may lift share count to 6.2M - Stock Titan
Beyond Air Q2 net loss hits USD 7.9M - Medical Buyer
Cash per share of Beyond Air, Inc. – FWB:48L - TradingView
XAIR Q2 2026 Earnings: Narrower Loss Fails to Stem 8.74% Stock DeclineEarnings Sentiment Score - vinanet.vn
Beyond Air Sticks to Revenue Targets as LungFit PH Gen II FDA Decision Nears - finance.biggo.com
Finanzdaten der Beyond Air Inc-Aktie (XAIR)
Umsatz
Nettogewinn
Free Cashflow
ENV
Beyond Air Inc-Aktie (XAIR) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lin Yi-Chien | 10% Owner |
Oct 01 '26 |
Buy |
2.80 |
15,393 |
43,100 |
145,393 |
| Lin Yi-Chien | 10% Owner |
Sep 30 '26 |
Buy |
2.71 |
2,000 |
5,420 |
130,000 |
| Lin Yi-Chien | 10% Owner |
Sep 29 '26 |
Buy |
2.69 |
3,000 |
8,070 |
128,000 |
| Goodman Robert Scott | Chief Executive Officer |
Jul 29 '26 |
Buy |
5.76 |
34,722 |
199,999 |
34,822 |
| MOORHEAD DANIEL J | Chief Financial Officer |
Jul 29 '26 |
Buy |
5.76 |
4,340 |
24,998 |
4,340 |
0.47%
7.98%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):